Aoxing Pharmaceutical Company, Inc.
- Jurisdiction
China - ISIN
US03740A1060 (AOXG )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. Read full profile
Fundamentals
- Net revenue
€25.68M - Gross margin
76.2% - EBIT
€825.31K - EBIT margin
3.2% - Net income
-€1.25M - Net margin
-4.9%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions